What is the next best step if a Clostridioides difficile (C. Diff) test result from an infectious diarrhea panel is indeterminate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Next Best Step for Indeterminate C. Diff Test Result

When a C. difficile test returns as indeterminate (typically GDH positive/toxin negative), perform a nucleic acid amplification test (NAAT/PCR) to arbitrate the discordant result. 1, 2

Understanding the Indeterminate Result

An indeterminate result most commonly occurs in multi-step testing algorithms when:

  • GDH (glutamate dehydrogenase) is positive - indicating C. difficile organism is present 2
  • Toxin A/B enzyme immunoassay (EIA) is negative - indicating no detectable toxin 1

This discordant pattern requires arbitration because it cannot distinguish between colonization and active infection 1, 2.

Immediate Action: Arbitration Testing

Perform NAAT/PCR testing on the same specimen to resolve the discordant result 1, 2. This three-step algorithm (GDH + toxin, arbitrated by NAAT when discordant) provides definitive results for approximately 85-92% of samples 1, 2.

Clinical Decision-Making Based on Results

If NAAT Positive AND Toxin Positive:

  • Treat immediately - these patients have true infection with significantly worse outcomes 1, 2
  • Complication rate: 7.6%, mortality: 8.4%, longer duration of diarrhea 1, 2
  • First-line treatment: Oral vancomycin 125 mg four times daily for 10 days OR fidaxomicin 200 mg twice daily for 10 days 1

If NAAT Positive BUT Toxin Negative:

  • Generally do NOT treat - these patients represent colonization, not active infection 1, 2
  • Complication rate: 0%, mortality: 0.6%, outcomes similar to patients without C. difficile 1, 2
  • Consider alternative causes of diarrhea 2
  • Exception: Treat if severe clinical illness is present (see below) 1

When to Treat Empirically While Awaiting Results

Consider empirical treatment with oral vancomycin 125 mg four times daily if ANY of the following are present 1, 3:

  • Severe disease markers: WBC ≥15,000 cells/mL, serum creatinine >1.5 mg/dL, high fever 1, 3
  • Fulminant disease: Hypotension, shock, ileus, megacolon 1
  • Significant clinical symptoms: ≥3 unformed stools in 24 hours conforming to container shape 1, 2
  • Recent antibiotic exposure - strong risk factor for true CDI 1, 2
  • Substantial laboratory delay (>48 hours for results) 1

Critical Pitfalls to Avoid

Do NOT Repeat Testing Within 7 Days

Avoid repeat testing during the same diarrheal episode - diagnostic yield is only 2% and increases false-positive results 4, 2. The negative predictive value of highly sensitive tests exceeds 99% 4.

Exception for repeat testing: Only consider if 4:

  • Clinical symptoms worsen significantly 4
  • Epidemic setting with high CDI acquisition rates 4
  • Recurrence after successful treatment and symptom resolution 4

Do NOT Test Asymptomatic Patients

Never test for test-of-cure - >60% of successfully treated patients remain C. difficile positive 4, 2.

Do NOT Test Infants ≤12 Months

Colonization rates exceed 40% in this age group, making testing unreliable 4, 2.

Supportive Management

Regardless of treatment decision 1, 5:

  • Discontinue the offending antibiotic as quickly as possible 1, 5
  • Stop unnecessary proton pump inhibitors to reduce recurrence risk 1, 2
  • Implement contact precautions for infection control 3

If Multiple Tests Remain Negative

For patients with persistent diarrhea and multiple negative C. difficile tests, investigate alternative causes 1:

  • Celiac disease 1
  • Protozoal infections (Giardia, Cryptosporidium) 1
  • Inflammatory bowel disease 1
  • Other bacterial pathogens (Salmonella, Shigella, Campylobacter) 4

References

Guideline

Diagnosis and Management of Chronic Diarrhea with Indeterminate Clostridioides difficile Toxin Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

C. difficile Infection Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Suspected C. difficile Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.